Insights & Discussion
Consuming carrots reduces the risk of gastric cancer by an indicated 26%.
Using specific search terms related to gastric cancer and carrot consumption, a comprehensive search through databases such as PubMed, Cochrane Library, Scopus, ScienceDirect, and some Persian databases was conducted. Comprehensive Meta Analysis/2.0 software was utilized for statistical analysis.
The initial search yielded 81 articles, but only 5 met the inclusion and exclusion criteria and were included in the study. Without mentioning specifics, a fixed effects model determined a significant reduction in the risk of gastric cancer associated with carrot consumption. The results showed no indication of publication bias through a funnel graph depiction. The results demonstrate an inverse relationship between carrot consumption and the risk of gastric cancer.
Discover Related Insights
Crocin, a compound derived from saffron, has shown considerable potential in hindering tumor growth and improving immune status, across various malignant tumors.
2023 PeerJ Advances on the anti-tumor mechanisms of the carotenoid Crocin Bao X, Hu J, Zhao Y, Jia R, Zhang H, Xia L
Review Article Anti-Tumour Breast Cancer Cervical Cancer
The methodology for the study involved an in-depth review of modern pharmacological studies that have analyzed the therapeutic effects of crocin, a natural compound that can be extracted from saffron. Various anti-tumor effects were assessed including the induction of tumor cell death (apoptosis), restrictions on tumor cell proliferation, and potential barriers to invasion and metastasis of these cells. The potential for enhancement of sensitivity to chemotherapy and improvement of immune status were also examined.
Following the review, the study revealed that crocin has significant anti-tumor properties. It showed that this natural compound can induce apoptosis in tumor cells, inhibit their expansion and progression, and even prevent their invasiveness and metastasis. Furthermore, crocin demonstrated the potential to enhance the body’s responsiveness to chemotherapy and help boost the immune system. These effects were observed across a range of different malignant tumors, including stomach, liver, cervical, breast, and colorectal cancers.
Consuming carrots can significantly decrease the risk of cancer.
2023 Critical Reviews in Food Science and Nutrition Carrot intake is consistently negatively associated with cancer incidence: A systematic review and meta-analysis of prospective observational studies Ojobor CC, O’Brien GM, Siervo M, Ogbonnaya C, Brandt K
Meta-Analysis Cancer Carrot
The methodology used in this research involved examining the links between carrot intake and the incidence of cancer. The scope was broad, examining all studies published before June 2022 that offered risk estimates connecting cancer incidence with either carrot consumption, α-carotene intake, or α-carotene plasma levels. Possible sources of such studies included those found via digital searches, manually identified within other studies, or garnered from existing reviews. Analysis was carried out comparing the highest and lowest reported intakes from prospective studies, estimating summary relative risks using a random-effects model.
The study's results indicated a strong correlation between carrot consumption and a notable reduction in cancer risk. This conclusion was derived from the analysis of 198 observational studies, 50 of which were prospective studies involving a total of 52,000 cases that specifically recorded carrot intake. Comparatively, on the correlation between α-carotene plasma levels and cancer risk, analysis from 30 prospective studies with 9,331 cases indicated that a higher presence of α-carotene also resulted in decreased cancer risk. Despite a moderate variance between studies, these findings serve as significant evidence in support of the anticancer benefits of carrots.
Ellagic acid, found naturally in pomegranates, significantly inhibits growth and migration of gastric cancer cells without causing notable side effects.
2022 Human & Experimental Toxicology The effects of ellagic acid and other pomegranate (Punica granatum L.) derivatives on human gastric cancer AGS cells Cheshomi H, Bahrami AR, Rafatpanah H, Matin MM
Experimental Study Ellagic Acid Pomegranate Stomach Cancer
In the methodology of this study, High Performance Liquid Chromatography (HPLC) was employed to detect the presence of Ellagic Acid (EA) in samples. Various methods were then used to determine the various anti-cancer properties of different concentrations of pomegranate fruit juice, pomegranate peel extract, and pure EA. This included an MTT assay, apoptosis and scratch assay, gelatin zymography and quantitative RT-PCR. Additionally, the study examined the impact of these compounds on immunocompromised C57BL/6 mice carrying human gastric cancer tumors.
Extending to discussing the results, it was found that EA inhibited both the proliferation and migration of gastric cancer cells in mice and altered gene expressions related to apoptosis and inflammation. The treatments with EA or pomegranate extract resulted in a noticeable decrease in tumor size in the lab mice. No significant side effects were reported from EA use. In sum, the results showed EA's potential as a safe and effective anti-cancer agent specific to gastric adenocarcinoma.
Carotenoid-rich foods like orange carrots were more effective in mitigating Non-alcoholic fatty liver disease than those with low carotenoid levels.
2022 Frontiers in Nutrition Carotenoids in orange carrots mitigate non-alcoholic fatty liver disease progression Balbuena E, Cheng J, Eroglu A
Experimental Study Carrot NAFLD Orange
In this study, male C57BL/6J mice were randomly assigned to one of four experimental diets for a period of 15 weeks: a low-fat diet, a high-fat diet, a high-fat diet with 20% white carrot powders, or a high-fat diet with 20% orange carrot powders.
Observations revealed that those mice on the high-fat diet enriched with carotenoids from the orange carrots gained less weight and displayed less hepatic lipid deposition compared to the white carrot group. Moreover, lower levels of triglyceride content were seen in the orange carrot group. The increase of particular proteins indicated that carotenoids found in orange carrots improved β-oxidation, thereby inhibiting NAFLD development more significantly. Further examination showed noticeably higher mRNA and protein levels of a particular transcription factor.
Phytochemicals in carrots, particularly carotenoids, are effective at reducing eyesight degeneration and treating chronic eye defects due to their antioxidant and anti-inflammatory properties.
2021 SSRN Electronic Journal The Nutraceutical potential of Carrots carotenoids in Chronic Eyes Defects (CEDs): A Review Taiwo EA, Abdulkareem TT, Fajemisin E
Review Article Age-Related Macular Degeneration Carrot Cataracts
Throughout the review process, seventy original research and review articles were examined, all published between 2000 and 2020 across four major journal databases: Elsevier, PubMed, ResearchGate and Plos One. The focus of the search was directed by six keywords, centring on both in-vivo and in-vitro study results related to the topic of interest.
Among the various findings, it was consistently revealed that carrots contain a multitude of bioactive compounds, notably carotenoids, which have been proven to be effective in halting and treating eye degenerations including Nyctalopia, Myopia, Cataracts, Age-related Macular Diseases and Glaucoma. Carotenoids have been found to work as potent antioxidants and anti-inflammatory agents, defending eyes against vision loss due to oxidative stress. Thus, the increased consumption of carrots can potentially serve as a natural therapeutic approach and enhancer of vision.
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.